HIF-1α was found to be overexpressed in esophageal squamous cell carcinoma (ESCC), and in vitro and in vivo experiments demonstrated that PX-478 has significant antitumor activity against HIF-1α-overexpressing ESCC tumors [93]. This evidence concerns the gene HIF1A and esophageal squamous cell carcinoma.